09:00 AM, 27th Jan 2026
Pursuant to Regulation 30 0f Listing Regulations please find enclosed Press Release- Wockhardts Fifth Novel Antibiotic Foviscu (WCK 4282) Matches Gold Standard Meropenem in pivotal Phase 3 Trial as First-Line Therapies Fail Against Rising Resistance.: